title: Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.
authors.affiliation: Brigham and Women's Hospital Heart &Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
authors.forename: Alon
authors.initials: A
authors.lastname: Eisen
authors.affiliation: Brigham and Women's Hospital Heart &Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D001241:Aspirin